Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma – A DAHANCA 19 study-Reference-Cited by-同舟云学术

Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma – A DAHANCA 19 study

Published:2024-04 Issue: Volume:193 Page:110149
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Kristensen Morten Horsholt,Sørensen Mia Kristina,Tramm Trine^ORCID,Alsner Jan^ORCID,Sørensen Brita Singers,Maare Christian^ORCID,Johansen Jørgen^ORCID,Primdahl Hanne,Bratland Åse,Kristensen Claus Andrup,Andersen Maria,Lilja-Fischer Jacob Kinggaard,Holm Anne Ivalu Sander,Samsøe Eva^ORCID,Hansen Christian Rønn,Zukauskaite Ruta,Overgaard Jens,Eriksen Jesper Grau

Funder

Danish Cancer Society

Region Midtjyllands Sundhedsvidenskabelige Forskningsfond

Publisher

Elsevier BV

Reference45 articles.

1. Radiation oncology in the era of precision medicine;Baumann;Nat Rev Cancer,2016

2. Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV -positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts;Lassen;Int J Cancer,2021

3. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis;Overgaard;Radiother Oncol,2011

4. OC-0105 Incidence and survival after HPV+ and HPV- oropharynx cancer in Denmark 1986–2020 - A DAHANCA study;Lassen;Radiother Oncol,2023

5. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis;Bourhis;Lancet,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-escalated radiation for human papillomavirus virus-related oropharyngeal cancer: Who, why, what, where, when, how, how much…and what next?;Radiotherapy and Oncology;2024-11

2. Interobserver variation in organs at risk contouring in head and neck cancer according to the DAHANCA guidelines;Radiotherapy and Oncology;2024-08